| Janssen-Cilag AG - Lazcluze 80 mg, Filmtabletten | | 69751 | | 01 | | Lazcluze 80 mg | | Filmtabletten | | L01EB09 | | | | 07.02.2025 | | |
| | Composition | | lazertinibum 80 mg ut lazertinibi mesilas monohydricus, silica hydrophobica colloidalis, cellulosum microcristallinum, mannitolum, carmellosum natricum conexum corresp. natrium max. 0.8 mg, magnesii stearas, Überzug: copolymerum macrogolo et alcoholi poly(vinylico) constatum, talcum, E 171, glyceroli monocaprylocapras, E 172 (flavum), poly(alcohol vinylicus), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Lazertinibum | 80 mg |
| | | | Inactive agents | | additional_information |
|---|
| (Flavum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | Copolymerum Macrogolo et Alcoholi Poly(Vinylico) Constatum | | Überzug | | E 171 | | color. | | E 172 | | color. | | Glyceroli Monocaprylocapras | | | | Magnesii Stearas | | | | Mannitol | | | | Poly(Alcohol Vinylicus) | | | | Pro Compresso Obducto | | | | Silica Hydrophobica Colloidalis | | | | Talcum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 56 | PR | PR | A | | No |
|
|
